Average Co-Inventor Count = 3.65
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Inc. (20 from 1,970 patents)
2. Medarex Inc. (2 from 152 patents)
3. E. R. Squibb Sons, Inc. (1 from 1,624 patents)
20 patents:
1. 11230597 - Methods of treatment using an interferon gamma inhibitor
2. 11156600 - Assay for detecting TH1 and TH2 cell populations
3. 10156562 - Assay for detecting Th1 and Th2 cell populations
4. 8906371 - Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitors
5. 8529893 - Methods for treating IFN-γ mediated diseases using human anti-IFN-γ neutralizing antibodies as selective IFN-gamma pathway inhibitors
6. 8202976 - Nucleic acid molecules that encode human anti-IFN-gamma neutralizing antibodies as selective IFN-gamma pathway inhibitors
7. 8148109 - Interferon-like proteins and uses thereof
8. 7811791 - Interferon-like molecules and uses thereof
9. 7790859 - Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitors
10. 7335743 - Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitors
11. 7041796 - C3b/C4b Complement Receptor-like molecules and uses thereof
12. 6992175 - Nucleic acids encoding Eph-like receptor tyrosine kinases
13. 6656707 - C3b/C4b complement receptor-like molecules and uses thereof
14. 6479250 - Eck receptor ligands
15. 6087167 - Eck receptor ligands